Propofol
- Generic Name
- Propofol
- Brand Names
- Diprivan
- Drug Type
- Small Molecule
- Chemical Formula
- C12H18O
- CAS Number
- 2078-54-8
- Unique Ingredient Identifier
- YI7VU623SF
- Background
Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. ...
- Indication
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
- Associated Conditions
- -
- Associated Therapies
- Induction of anesthesia therapy, Maintenance of anesthesia therapy, Monitored anesthesia care sedation, Sedative therapy
Influence of Propofol on Alveolar Macrophage in Asthmatic Patients
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2009-03-31
- Lead Sponsor
- Nanjing Medical University
- Target Recruit Count
- 80
- Registration Number
- NCT00676416
- Locations
- 🇨🇳
Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu, China
The Effect of Sedation on Eye Movements
- Conditions
- Interventions
- First Posted Date
- 2008-03-28
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- University of Alabama at Birmingham
- Target Recruit Count
- 65
- Registration Number
- NCT00646646
- Locations
- 🇺🇸
General Clinical Research Center, Birmingham, Alabama, United States
The Effect on Cognition of Terminating ECT Induced Seizures With Propofol
- Conditions
- Interventions
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2021-06-08
- Lead Sponsor
- Loma Linda University
- Target Recruit Count
- 20
- Registration Number
- NCT00616759
- Locations
- 🇺🇸
Loma Linda University, Loma Linda, California, United States
Intravenous Versus Inhalational Anesthesia in Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2008-02-14
- Last Posted Date
- 2015-07-13
- Lead Sponsor
- Columbia University
- Target Recruit Count
- 58
- Registration Number
- NCT00615472
- Locations
- 🇺🇸
Columbia Unviversity, Deparment of Anesthesiology, New York, New York, United States
Ketamine Compared to Propofol for Pediatric GI Endoscopy
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2009-07-02
- Target Recruit Count
- 34
- Registration Number
- NCT00614159
Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol
- Conditions
- Interventions
- First Posted Date
- 2008-01-04
- Last Posted Date
- 2008-01-04
- Lead Sponsor
- Klinikum Ludwigshafen
- Target Recruit Count
- 120
- Registration Number
- NCT00586118
Safety of Driving After Minor Surgery with Monitored Anesthesia Care
- Conditions
- Interventions
- First Posted Date
- 2007-12-20
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Rush University Medical Center
- Target Recruit Count
- 625
- Registration Number
- NCT00577200
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
Propofol's Hypnotic and Memory Effects
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2016-05-06
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 102
- Registration Number
- NCT00576615
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Sugammadex After Continuous Infusion of Rocuronium During Sevoflurane and Propofol Anesthesia (P05949; MK-8616-028)
- Conditions
- Interventions
- First Posted Date
- 2007-11-16
- Last Posted Date
- 2019-11-25
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 52
- Registration Number
- NCT00559468
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-10-11
- Last Posted Date
- 2015-04-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 89
- Registration Number
- NCT00542542
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.